Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Serial Plasma Genotyping to Guide the Adaptive Treatment of Advanced NSCLC Receiving First-line Pembrolizumab

NCT04166487 is registered in ClinicalTrials.gov with Julia K. Rotow, MD as lead sponsor.

NCT NCT04166487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04166487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Serial Plasma Genotyping to Guide the Adaptive Treatment of Advanced NSCLC Receiving First-line Pembrolizumab
Lead sponsor
Julia K. Rotow, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 13, 2020
Completion date
December 1, 2026
Enrollment
40 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic non-small cell lung cancer, nsclc stage iv